Omega Funds

Omega Funds is a leading international investment firm that creates and invests in life sciences companies that target the world’s most urgent medical needs. Our investment decisions are honed by cross-disciplinary teams analyzing platforms and products across disease areas. We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine, and others. We work in partnership with our companies’ founders, management teams, and fellow co-investors to provide necessary resources: domain knowledge and perspective, network connectivity, and capital. We are stage agnostic; it doesn't matter if you are an early seed or a late-stage public financing. Large markets or rare diseases. Established targets or novel technologies. We are guided by our conviction in people, products, and breakthrough ideas, not by conventional categories. Our investments span a variety of instruments from early venture rounds to late-stage investing, direct secondary transactions, and company founding and creation.